In another study, Zhuo et al. highlighted the ability of sinomenine to improve DSS-induced colitis, interfering with the Nrf2/NQO-1 signaling and reducing the levels of pro-inflammatory and pro-fibrotic molecules (TNF-α, IL-6, and iNOS) [79]. This evidence concerns the gene NQO1 and colitis.